Literature DB >> 17171359

Assessment of insulin resistance in fructose-fed rats with 125I-6-deoxy-6-iodo-D-glucose, a new tracer of glucose transport.

Pascale Perret1,2, Lotfi Slimani3,4, Arnaud Briat3,4, Danièle Villemain3,4, Serge Halimi5, Jacques Demongeot4,6, Daniel Fagret3,4, Catherine Ghezzi3,4.   

Abstract

PURPOSE: Insulin resistance, characterised by an insulin-stimulated glucose transport defect, is an important feature of the pre-diabetic state that has been observed in numerous pathological disorders. The purpose of this study was to assess variations in glucose transport in rats using (125)I-6-deoxy-6-iodo-D-glucose (6DIG), a new tracer of glucose transport proposed as an imaging tool to assess insulin resistance in vivo.
METHODS: Two protocols were performed, a hyperinsulinaemic-euglycaemic clamp and a normoinsulinaemic-normoglycaemic protocol, in awake control and insulin-resistant fructose-fed rats. The tracer was injected at steady state, and activity in 11 tissues and the blood was assessed ex vivo at several time points. A multicompartmental mathematical model was developed to obtain fractional transfer coefficients of 6DIG from the blood to the organs.
RESULTS: Insulin sensitivity of fructose-fed rats, estimated by the glucose infusion rate, was reduced by 40% compared with control rats. At steady state, 6DIG uptake was significantly stimulated by insulin in insulin-sensitive tissues of control rats (basal versus insulin: diaphragm, p < 0.01; muscle, p<0.05; heart, p<0.001), whereas insulin did not stimulate 6DIG uptake in insulin-resistant fructose-fed rats. Moreover, in these tissues, the fractional transfer coefficients of entrance were significantly increased with insulin in control rats (basal vs insulin: diaphragm, p<0.001; muscle, p<0.001; heart, p<0.01) whereas no significant changes were observed in fructose-fed rats.
CONCLUSION: This study sets the stage for the future use of 6DIG as a non-invasive means for the evaluation of insulin resistance by nuclear imaging.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17171359      PMCID: PMC2705461          DOI: 10.1007/s00259-006-0267-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  40 in total

1.  Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model.

Authors:  Katherine V Williams; Alessandra Bertoldo; Bruno Mattioni; Julie C Price; Claudio Cobelli; David E Kelley
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

Review 2.  Global and societal implications of the diabetes epidemic.

Authors:  P Zimmet; K G Alberti; J Shaw
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 3.  Insulin sensitivity and its measurement: structural commonalities among the methods.

Authors:  J Radziuk
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

4.  Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography.

Authors:  K V Williams; J C Price; D E Kelley
Journal:  Diabetes       Date:  2001-09       Impact factor: 9.461

Review 5.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

6.  Time dependence of insulin action in muscle and adipose tissue in the rat in vivo. An increasing response in adipose tissue with time.

Authors:  D E James; K M Burleigh; E W Kraegen
Journal:  Diabetes       Date:  1985-10       Impact factor: 9.461

7.  Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans.

Authors:  Kirsi A Virtanen; Peter Lönnroth; Riitta Parkkola; Pauliina Peltoniemi; Markku Asola; Tapio Viljanen; Tuula Tolvanen; Juhani Knuuti; Tapani Rönnemaa; Risto Huupponen; Pirjo Nuutila
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

8.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

Authors:  J Eriksson; A Franssila-Kallunki; A Ekstrand; C Saloranta; E Widén; C Schalin; L Groop
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

9.  Effects of isotonic fluid load on plasma water and extracellular fluid volumes in the rat.

Authors:  M Larsson; J Ware
Journal:  Eur Surg Res       Date:  1983       Impact factor: 1.745

10.  Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis.

Authors:  M I Harris; R Klein; T A Welborn; M W Knuiman
Journal:  Diabetes Care       Date:  1992-07       Impact factor: 19.112

View more
  4 in total

1.  Oral ethinylestradiol-levonorgestrel attenuates cardiac glycogen and triglyceride accumulation in high fructose female rats by suppressing pyruvate dehydrogenase kinase-4.

Authors:  Kehinde Samuel Olaniyi; Lawrence Aderemi Olatunji
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-01       Impact factor: 3.000

2.  In vivo assessment of cardiac insulin resistance by nuclear probes using an iodinated tracer of glucose transport.

Authors:  Arnaud Briat; Lotfi Slimani; Pascale Perret; Danièle Villemain; Serge Halimi; Jacques Demongeot; Daniel Fagret; Catherine Ghezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-26       Impact factor: 9.236

3.  Preclinical and clinical evaluation of a new method to assess cardiac insulin resistance using nuclear imaging.

Authors:  Pascale Perret; Lotfi Slimani; Gilles Barone-Rochette; Julien Vollaire; Arnaud Briat; Mitra Ahmadi; Marion Henri; Marie-Dominique Desruet; Romain Clerc; Alexis Broisat; Laurent Riou; François Boucher; Frédérique Frouin; Loïc Djaileb; Alex Calizzano; Gérald Vanzetto; Daniel Fagret; Catherine Ghezzi
Journal:  J Nucl Cardiol       Date:  2021-01-27       Impact factor: 3.872

4.  The impact of sugar-sweetened beverage intake on rat cardiac function.

Authors:  Natasha Driescher; Danzil E Joseph; Veronique R Human; Edward Ojuka; Martin Cour; Nkanyiso Hadebe; Dirk Bester; Jeanine L Marnewick; Sandrine Lecour; Amanda Lochner; M Faadiel Essop
Journal:  Heliyon       Date:  2019-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.